Zoetis: Why I'm Doubling Down On My Worst 2025 Pick

2026-02-16 08:15:00 ET

One year ago, I rated Zoetis ( ZTS ) a 'buy' following its Q4 2024 earnings report. After the stock fell in response to lower-than-expected guidance, I argued that management was being overly conservative and the dip presented a buying opportunity. Unfortunately, Zoetis turned out to be my worst stock pick when I reviewed my 2025 year-end performance . The stock fell -23% in the past year, badly lagging the S&P 500 and single-handedly reducing my average return by nearly 200 basis points to 34.3%. Biotech had an exceptional year in 2025, so it stung that my worst performing pick wasn't a high-risk/high-reward speculative play. I tried to play it safe, but got burned anyway....

Read the full article on Seeking Alpha

For further details see: